ALLR

ALLR

USD

Allarity Therapeutics Inc. Common Stock

$1.295-0.035 (-2.632%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$1.330

Máximo

$1.340

Mínimo

$1.280

Volume

0.38M

Fundamentos da empresa

Capitalização de mercado

18.8M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

7.00M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.614Atual $1.295Máximo $2.35

Notícias relacionadas

Analyst Upgrades

Ascendiant Capital Maintains Buy on Allarity Therapeutics, Raises Price Target to $9.25

Ascendiant Capital analyst Edward Woo maintains Allarity Therapeutics with a Buy and raises the price target from $9 to $9.25.

Ver mais
Ascendiant Capital Maintains Buy on Allarity Therapeutics, Raises Price Target to $9.25
GlobeNewswire

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

- Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistant and Refractory Ovarian Cancer Patients receiving stenoparib/2X-121 twice daily - Two patients

Ver mais
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months